What is Inflammatory Bowel Disease?
Inflammatory Bowel Disease (IBD) is a term used to describe any condition of the bowel in which it becomes inflamed. Common types of IBD include ulcerative colitis, and Crohn’s disease. IBD, if left untreated, can lead to severe complications. Current treatment for IBD involves addressing the inflammation and individual symptoms, in hopes that treatment will lead to long-term remission of the IBD.
Inflammatory Bowel Disease Clinical Trials
We have many different research studies of Inflammatory Bowel Disease (IBD) for patients with known diagnoses of IBD who have not found their current treatment to be effective, or are willing to contribute to research. Patients who qualify for our IBD clinical trials may receive compensation for their time, see a board-certified physician at no cost to them, and have access to possible investigational medications.
What is the purpose of a clinical trial?
The purpose of conducting clinical trials for IBD is to determine the most effective and safe treatment options, and how those might apply differently to different individuals. Clinical trials are the method of translating research into new medicines and treatments that can provide new and improved patient outcomes. The lengthiest step in conducting clinical trials is often finding participants for the trials. The outcomes of clinical trials are one of the vital considerations of the U.S. Food and Drug Administration’s drug approval process. Without FDA approval, there could be no advances in patient therapeutics.
How Do I Get Involved?
If you have Inflammatory Bowel Disease (IBD) and want to get involved in a clinical trial for IBD, you should fill out the form at the top of this page, and you may be matched to a clinical trial that is right for you.
Clinicians Practicing at Inflammatory Bowel Disease (IBD)
J. Casey Chapman, M.D.
Regional Medical Research Director